Purpose: To compare between the coplanar and non-coplanar fields regarding planning target
volume (PTV) coverage, conformity index and preservation of organs at risk (heart-lungs-esophagus
and spinal cord). Materials and Methods: 10 patients presented with stage IIIA or IIIB NSCLC
with a tumor located in the middle or lower lobes. Because of this location, the heart is one of the
main organs at risk. Two plans, coplanar and non-coplanar 3 dimensional conformal radiotherapy
plans are performed for each patient. All treatment plans are created using Xio - Computerized
medical system treatment planning system. The prescribed dose is 64 Gy in 32 fractions. Results:
For both plans, the maximum dose to the PTV doesn’t exceed 110% of the prescribed dose; the
95% isodose (60.8 Gy) covers at least 95% of the PTV volume and the mean conformity index values
are also very similar 0.59 vs 0.61 for coplanar and non-coplanar plans respectively without
statistically significant difference (P = 0.1711). Regarding organs at risk, large advantage for adding
a non-coplanar field in the preservation of the heart is observed. The mean V30 values for noncoplanar
plan are 17.3 Gy versus 28.9 Gy for the coplanar plan with statistically significant difference
(P = 0.0060). Also, the mean V40 and V50 values for the non coplanar compared to coplanar
plan are 12.6 Gy and 7.9 Gy versus 23.1 Gy and 14.9 Gy respectively, and these differences are statistically
significant (P = 0.0162) (P = 0.0084). No statistically significant differences are found
between coplanar and non-coplanar plans for lungs, esophagus or the spinal cord. Conclusion: Using
non-coplanar beams in the irradiation of middle and lower lung tumors significantly reduces
the radiation dose to the heart with the same target volume coverage and conformity index.
References
[1]
Hensing, T. and Socinski, M.A. (1999) Combined Modality Therapy in the Nonsurgical Management of Unresectable Stage III Non-Small Cell Lung Cancer. Current Opinion in Pulmonary Medicine, 5, 194-200. http://dx.doi.org/10.1097/00063198-199907000-00003
[2]
Albain, K., Scott, C., Rusch, V., et al. (2003) Phase III Comparison of Concurrent Chemotherapy Plus Radiotherapy (CT/RT) and CT/RT Followed by Surgical Resection for Stage IIIA(pN2) Non-Small Cell Lung Cancer (NSCLC): Initial Results from Intergroup Trial 0139 (RTOG 93-09). Proceedings of American Society of Clinical Oncology, 22, 621.
[3]
Belderbos, J., De Jaeger, K., Heemsbergen, W., et al. (2003) First Results of a Phase I/II Dose Escalation Trial in Non-Small Cell Lung Cancer Using Three-Dimensional Conformal Radiotherapy. Radiotherapy and Oncology, 66, 119-126. http://dx.doi.org/10.1016/s0167-8140(02)00377-8
[4]
American Society of Clinical Oncology (1997) Clinical Practice Guidelines for the Treatment of Unresectable Non-Small Cell Lung Cancer. Journal of Clinical Oncology, 15, 2996-3018.
[5]
Le Chevalier, T., Arrigada, R., Quoix, E., et al. (1991) Radiotherapy Alone versus Combined Chemotherapy and Radiotherapy in Non-Resectable Non-Small Cell Lung Cancer: First Analysis of a Randomized Trial. Journal of the National Cancer Institute, 83, 417-423. http://dx.doi.org/10.1093/jnci/83.6.417
[6]
Chapet, O., Thomas, E., Kessler, M., Fraass, B.A. and Haken, R.K.T. (2005) Esophagus Sparing in Lung Tumor Irradiation: An EUD-Based Optimization Technique. International Journal of Radiation Oncology*Biology*Physics, 63, 179-187. http://dx.doi.org/10.1016/j.ijrobp.2005.01.028
[7]
Hayman, J.A., Martel, M.K., Ten Haken, R.K., et al. (2001) Dose Escalation in Non-Small-Cell Lung Cancer Using Three-Dimensional Conformal Radiation Therapy: Update of a Phase I Trial. Journal of Clinical Oncology, 19, 127-136.
[8]
Cutter, D.J., Darby, S.C. and Yusuf, S.W. (2011) Risks of Heart Disease after Radiotherapy. Texas Heart Institute Journal, 38, 257-258.
[9]
Early Breast Cancer Trialists’ Collaborative Group (2011) Effect of Radiotherapy after Breast Conserving Surgery on 10-Year Recurrence and 15-Year Breast Cancer Death: Meta-Analysis of Individual Patient Data for 10,801 Women in 17 Randomised Trials. The Lancet, 378, 1707-1716. http://dx.doi.org/10.1016/S0140-6736(11)61629-2
[10]
Rademaker, J., Schoder, H., Ariaratnam, N.S., et al. (2008) Coronary Artery Disease after Radiation Therapy for Hodgkin’s Lymphoma: Coronary CT Angiography Findings and Calcium Scores in Nine Asymptomatic Patients. American Journal of Roentgenology, 191, 32-37. http://dx.doi.org/10.2214/AJR.07.3112
[11]
Tamura, A., Takahara, Y., Mogi, K. and Katsumata, M. (2007) Radiation-Induced Valvular Disease Is the Logical Consequence of Irradiation. General Thoracic and Cardiovascular Surgery, 55, 53-56. http://dx.doi.org/10.1007/s11748-006-0070-x
[12]
Heidenreich, P.A., Schnittger, I., Strauss, H.W., et al. (2007) Screening for Coronary Artery Disease after Mediastinal Irradiation for Hodgkin’s Disease. Journal of Clinical Oncology, 25, 43-49. http://dx.doi.org/10.1200/JCO.2006.07.0805
[13]
Reese, A.S., Das, S.K., Curie, C. and Marks, L.B. (2009) Integral Dose Conservation in Radiotherapy. Medical Physics, 36, 734-740. http://dx.doi.org/10.1118/1.3070585
[14]
Jabbari, S., Hansen, E.K. and Haas-Kogan, D.A. (2010) Non-Small Cell Lung Cancer. In: Hansen, E.K. and Roach, M., Eds., Hand Book of Evidence-Based Radiation Oncology, 2nd Edition, Springer, New York, Heidelberg, Dordrecht, London, Chap. 15, 222-247. http://dx.doi.org/10.1007/978-0-387-92988-0_15
[15]
Chapet, O., Khodri, M., Jalade, P., et al. (2006) Potential Benefits of Using Non-Coplanar Field and Intensity Modulated Radiation Therapy to Preserve the Heart in Irradiation of Lung Tumors in the Middle and Lower Lobes. Radiotherapy and Oncology, 80, 333-340. http://dx.doi.org/10.1016/j.radonc.2006.07.009
[16]
Cardinale, R., Benedict, S., Wu, Q., Zwicker, R., Gaballa, H.E. and Mohan, R. (1998) A Comparison of Three Stereotactic Radiotherapy Techniques, Arcs vs. Non-Coplanar Fixed Fields vs. Intensity modulation. International Journal of Radiation Oncology*Biology*Physics, 42, 431-436. http://dx.doi.org/10.1016/S0360-3016(98)00206-5
[17]
Rossi, L., Breedveld, S., Heijmen, B.J., Voet, P.W.J., Lanconelli, N. and Aluwini, S. (2012) On the Beam Direction Search Space in Computerized Non-Coplanar Beam Angle Optimization for IMRT-Prostate SBRT. Physics in Medicine and Biology, 57, 5441-5458. http://dx.doi.org/10.1088/0031-9155/57/17/5441
[18]
Dong, P., et al. (2013) 4π Non-Coplanar Liver SBRT: A Novel Delivery Technique. International Journal of Radiation Oncology*Biology*Physics, 85, 1360-1366. http://dx.doi.org/10.1016/j.ijrobp.2012.09.028
[19]
Dong, P., et al. (2013) 4π Noncoplanar Stereotactic Body Radiation Therapy for Centrally Located or Larger Lung Tumors. International Journal of Radiation Oncology*Biology*Physics, 86, 407-413. http://dx.doi.org/10.1016/j.ijrobp.2013.02.002
[20]
Bedford, J.L., Henrys, A.J., Dearnaley, D.P. and Khoo, V.S. (2005) Treatment Planning Evaluation of Non-Coplanar Techniques for Conformal Radiotherapy of the Prostate. Radiotherapy and Oncology, 75, 287-92.
[21]
Hsieh, C.-H., Liu, C.-Y., Shueng, P.-W., et al. (2010) Comparison of Coplanar and Noncoplanar Intensity-Modulated Radiation Therapy and Helical Tomotherapy for Hepatocellular Carcinoma. Radiation Oncology, 5, 40.
[22]
Chen, X.Y., Jin, D.W., Wang, S.L., et al. (2012) Non Coplanar Intensity-Modulated Radiation Therapy for Young Female Patients with Mediastinal Lymphoma. Journal of Applied Clinical Medical Physics, 13, 147-156.
[23]
D’Souza II, W.D. and Rosen, I.I. (2003) Nontumor Integral Dose Variation in Conventional Radiotherapy Treatment Planning. Medical Physics, 30, 2065-2071. http://dx.doi.org/10.1118/1.1591991
[24]
Nguyen, D., Dong, P., Long, T., et al. (2014) Integral Dose Investigation of Non-Coplanar Treatment Beam Geometries in Radiotherapy. Medical Physics, 41, 011905. http://dx.doi.org/10.1118/1.4845055
[25]
Hall, E.J. and Wuu, C.S. (2003) Radiation-Induced Second Cancers: The Impact of 3D-CRT and IMRT. International Journal of Radiation Oncology*Biology*Physics, 56, 83-88. http://dx.doi.org/10.1016/S0360-3016(03)00073-7
